skip to Main Content

Cell Partnership Exploited by Cancer to Turn Off Immune Response

Newsfeed image, light gray text on dark gray background
Blocking the partnership between regulatory T cells (Tregs) and dendritic cells may increase the efficacy of immunotherapy for pancreatic cancer, a new study suggests.

In the study, published in Cell Reports, investigators examined pancreatic ductal adenocarcinoma (PDA). Prior studies have shown a link between the early buildup of Tregs in tumors and a reduction in survival. Read more . . .

Back To Top